For more information or confidential assistance
se habla español

FDA Requests That Pfizer Update Zoloft Label

The U.S. Food and Drug Administration has asked Pfizer to update its Zoloft safety warnings to acknowledge that some studies have linked the antidepressant to infant heart defects. There is still no concrete evidence definitively connecting the drug to birth defects, but some researchers have noted an “increased risk of... Read more »

Effexor Birth Defect Trials to Move Forward

Pharmaceutical giant Pfizer is currently facing at least 68 product liability lawsuits filed in the federal court system with regard to its medication, Effexor (venlafaxine). The Effexor lawsuits claim the drug causes birth defects. In August of 2013, federal Effexor lawsuits were centralized into a multidistrict litigation (MDL), which is... Read more »

MDL Zoloft Lawsuit Trial Delayed

The first federal Zoloft lawsuit trial slated for MDL 2342 has been postponed until January 2015. The In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation is being overseen by the Honorable Cynthia M. Rufe, who issued a pretrial order on May 1 which indicated the case would be pushed back... Read more »